• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

识别氧化特异性表位的低水平IgM抗体与人类非酒精性脂肪性肝病相关。

Low levels of IgM antibodies recognizing oxidation-specific epitopes are associated with human non-alcoholic fatty liver disease.

作者信息

Hendrikx Tim, Watzenböck Martin L, Walenbergh Sofie M A, Amir Shahzada, Gruber Sabrina, Kozma Maria Ozsvar, Grabsch Heike I, Koek Ger H, Pierik Marieke J, Staufer Katharina, Trauner Michael, Kalhan Satish C, Jonkers Daisy, Hofker Marten H, Binder Christoph J, Shiri-Sverdlov Ronit

机构信息

Departments of Molecular Genetics, Pathology, and Internal Medicine, Division of Gastroenterology and Hepatology, School of Nutrition and Translational Research in Metabolism (NUTRIM) and School of Oncology and Developmental Biology (GROW), Maastricht University and Maastricht University Medical Center (MUMC), PO Box 616, 6200 MD, Maastricht, The Netherlands.

Departments of Laboratory Medicine, Surgery, and Internal Medicine III, Division of Gastroenterology And Hepatology, Medical University of Vienna, Vienna, Austria.

出版信息

BMC Med. 2016 Jul 22;14(1):107. doi: 10.1186/s12916-016-0652-0.

DOI:10.1186/s12916-016-0652-0
PMID:27443391
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4957359/
Abstract

BACKGROUND

Lipid oxidation of membrane phospholipids is accompanied by the formation of oxidation-specific epitopes (OSE). These epitopes are recognized by specific antibodies and represent danger-associated molecular patterns that are generated during chronic inflammatory processes. In a murine model for hepatic inflammation during non-alcoholic fatty liver disease (NAFLD), increased antibody levels targeting OSE were found to be protective. Here, our aim was to determine an association between OSE-specific antibody titers and NAFLD in humans.

METHODS

IgM and IgG levels with specificity for various OSE were assessed in the plasma of patients with NAFLD (n = 71) and healthy controls (n = 68). Antibody titers were comprehensively analyzed in patients with NAFLD after classification by histological evaluation of liver biopsies. Statistical analysis was performed to determine significant correlations and odds ratios. To study the specificity for NAFLD, plasma antibody titers were measured in patients with hepatitis C (n = 40) and inflammatory bowel disease (n = 62).

RESULTS

IgM titers against OSE were lower in patients with NAFLD compared to controls. Further biopsy-based classification of patients with NAFLD did not show any difference in IgM levels. Plasma IgM titers towards the P1 mimotope demonstrated an inverse correlation with markers for obesity, systemic inflammation, and liver damage. In contrast, hepatitis C and increased disease activity during inflammatory bowel disease was not associated with reduced IgM titers.

CONCLUSIONS

Our data highlight the importance of immune recognition of OSE by IgM antibodies in the pathophysiology of NAFLD.

摘要

背景

膜磷脂的脂质氧化伴随着氧化特异性表位(OSE)的形成。这些表位可被特异性抗体识别,代表了在慢性炎症过程中产生的危险相关分子模式。在非酒精性脂肪性肝病(NAFLD)期间肝脏炎症的小鼠模型中,发现靶向OSE的抗体水平升高具有保护作用。在此,我们的目的是确定人类中OSE特异性抗体滴度与NAFLD之间的关联。

方法

在NAFLD患者(n = 71)和健康对照者(n = 68)的血浆中评估对各种OSE具有特异性的IgM和IgG水平。在通过肝活检的组织学评估进行分类后,对NAFLD患者的抗体滴度进行了全面分析。进行统计分析以确定显著相关性和优势比。为了研究对NAFLD的特异性,在丙型肝炎患者(n = 40)和炎症性肠病患者(n = 62)中测量了血浆抗体滴度。

结果

与对照组相比,NAFLD患者中针对OSE的IgM滴度较低。基于活检对NAFLD患者进行的进一步分类未显示IgM水平有任何差异。针对P1模拟表位的血浆IgM滴度与肥胖、全身炎症和肝损伤标志物呈负相关。相比之下,丙型肝炎和炎症性肠病期间疾病活动增加与IgM滴度降低无关。

结论

我们的数据突出了IgM抗体对OSE的免疫识别在NAFLD病理生理学中的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab3d/4957359/b13f0b09154f/12916_2016_652_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab3d/4957359/455a60f739be/12916_2016_652_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab3d/4957359/91a9179f44f0/12916_2016_652_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab3d/4957359/2942933b77ef/12916_2016_652_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab3d/4957359/8d9c46321502/12916_2016_652_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab3d/4957359/b13f0b09154f/12916_2016_652_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab3d/4957359/455a60f739be/12916_2016_652_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab3d/4957359/91a9179f44f0/12916_2016_652_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab3d/4957359/2942933b77ef/12916_2016_652_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab3d/4957359/8d9c46321502/12916_2016_652_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab3d/4957359/b13f0b09154f/12916_2016_652_Fig5_HTML.jpg

相似文献

1
Low levels of IgM antibodies recognizing oxidation-specific epitopes are associated with human non-alcoholic fatty liver disease.识别氧化特异性表位的低水平IgM抗体与人类非酒精性脂肪性肝病相关。
BMC Med. 2016 Jul 22;14(1):107. doi: 10.1186/s12916-016-0652-0.
2
Anti-adipocyte antibody response in patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者的抗脂肪细胞抗体反应
J Gastroenterol Hepatol. 2015 May;30(5):900-8. doi: 10.1111/jgh.12856.
3
B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD).B2 淋巴细胞对氧化应激衍生抗原的反应有助于非酒精性脂肪性肝病(NAFLD)的发展。
Free Radic Biol Med. 2018 Aug 20;124:249-259. doi: 10.1016/j.freeradbiomed.2018.06.015. Epub 2018 Jun 18.
4
Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.氧化型低密度脂蛋白抗体/高密度脂蛋白胆固醇比值与晚期非酒精性脂肪性肝病瘦患者有关。
J Gastroenterol Hepatol. 2016 Sep;31(9):1611-8. doi: 10.1111/jgh.13335.
5
Autoantibodies and immune complexes to oxidation-specific epitopes and progression of aortic stenosis: Results from the ASTRONOMER trial.针对氧化特异性表位的自身抗体和免疫复合物与主动脉瓣狭窄的进展:ASTRONOMER试验的结果
Atherosclerosis. 2017 May;260:1-7. doi: 10.1016/j.atherosclerosis.2017.03.013. Epub 2017 Mar 9.
6
Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease.血清免疫球蛋白水平可预测非酒精性脂肪性肝病患者的纤维化程度。
J Hepatol. 2014 May;60(5):1055-62. doi: 10.1016/j.jhep.2014.01.010. Epub 2014 Jan 18.
7
Serum levels of immunoglobulins in an adult population and their relationship with nonalcoholic fatty liver disease.成年人血清免疫球蛋白水平及其与非酒精性脂肪性肝病的关系。
J Dig Dis. 2018 Aug;19(8):498-507. doi: 10.1111/1751-2980.12646. Epub 2018 Aug 23.
8
Natural antibodies to oxidation-specific epitopes: innate immune response and venous thromboembolic disease.氧化特异性表位的天然抗体:先天免疫反应与静脉血栓栓塞性疾病。
J Thromb Haemost. 2018 Jan;16(1):31-35. doi: 10.1111/jth.13874. Epub 2017 Nov 8.
9
High immunoglobulin-M levels to oxidation-specific epitopes are associated with lower risk of acute myocardial infarction.高免疫球蛋白-M 水平对氧化特异性表位与急性心肌梗死风险降低相关。
J Lipid Res. 2023 Jun;64(6):100391. doi: 10.1016/j.jlr.2023.100391. Epub 2023 May 19.
10
Serum IgA, IgG, and IgM antibodies directed against acetaldehyde-derived epitopes: relationship to liver disease severity and alcohol consumption.针对乙醛衍生表位的血清IgA、IgG和IgM抗体:与肝脏疾病严重程度及酒精摄入量的关系。
Hepatology. 1997 Jun;25(6):1418-24. doi: 10.1002/hep.510250619.

引用本文的文献

1
Mini-review: Serum immunoglobulins and MASLD.小型综述:血清免疫球蛋白与代谢相关脂肪性肝病
Front Immunol. 2025 Aug 15;16:1655560. doi: 10.3389/fimmu.2025.1655560. eCollection 2025.
2
Activated Immune and Complement C3 Are Potential Contributors in MASH via Stimulating Neutrophil Extracellular Traps.活化的免疫细胞和补体C3通过刺激中性粒细胞胞外诱捕网,可能在重症急性肾损伤中发挥作用。
Cells. 2025 May 19;14(10):740. doi: 10.3390/cells14100740.
3
Plasma levels of anti phosphocholine IgM antibodies are negatively correlated with bone mineral density in humans.

本文引用的文献

1
Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis.肝细胞中的脂毒性致死和亚致死应激信号传导:与非酒精性脂肪性肝炎发病机制的相关性
J Lipid Res. 2016 Oct;57(10):1758-1770. doi: 10.1194/jlr.R066357. Epub 2016 Apr 5.
2
Sialic Acid-Binding Immunoglobulin-like Lectin G Promotes Atherosclerosis and Liver Inflammation by Suppressing the Protective Functions of B-1 Cells.唾液酸结合免疫球蛋白样凝集素G通过抑制B-1细胞的保护功能促进动脉粥样硬化和肝脏炎症。
Cell Rep. 2016 Mar 15;14(10):2348-61. doi: 10.1016/j.celrep.2016.02.027. Epub 2016 Mar 3.
3
Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.
人体血浆中抗磷酸胆碱IgM抗体水平与骨矿物质密度呈负相关。
Sci Rep. 2025 Jan 15;15(1):2109. doi: 10.1038/s41598-025-85624-9.
4
The multifaceted roles of B lymphocytes in metabolic dysfunction-associated steatotic liver disease.B 淋巴细胞在代谢相关脂肪性肝病中的多效性作用。
Front Immunol. 2024 Sep 20;15:1447391. doi: 10.3389/fimmu.2024.1447391. eCollection 2024.
5
Tipping the Scale: Atheroprotective IgM-Producing B Cells in Atherosclerosis.颠覆传统:动脉粥样硬化中的抗动脉粥样硬化 IgM 产生 B 细胞。
Arterioscler Thromb Vasc Biol. 2024 Sep;44(9):1906-1915. doi: 10.1161/ATVBAHA.124.319847. Epub 2024 Jul 18.
6
The role of B cells in immune cell activation in polycystic ovary syndrome.B 细胞在多囊卵巢综合征免疫细胞激活中的作用。
Elife. 2023 Jul 4;12:e86454. doi: 10.7554/eLife.86454.
7
Antidepressants cheer up hepatic B1 B cells: Hope for the treatment of autoimmune liver diseases?抗抑郁药使肝脏B1 B细胞振作起来:自身免疫性肝病治疗的希望?
Front Immunol. 2023 Jan 17;13:1083173. doi: 10.3389/fimmu.2022.1083173. eCollection 2022.
8
Oxidized Lipids: Common Immunogenic Drivers of Non-Alcoholic Fatty Liver Disease and Atherosclerosis.氧化脂质:非酒精性脂肪性肝病和动脉粥样硬化常见的免疫原性驱动因素
Front Cardiovasc Med. 2022 Jan 10;8:824481. doi: 10.3389/fcvm.2021.824481. eCollection 2021.
9
Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity.代谢相关脂肪性肝病中先天性和适应性免疫的改变及其对COVID-19严重程度的影响。
Front Immunol. 2021 Mar 30;12:651728. doi: 10.3389/fimmu.2021.651728. eCollection 2021.
10
The Influence of a Conjugated Pneumococcal Vaccination on Plasma Antibody Levels against Oxidized Low-Density Lipoprotein in Metabolic Disease Patients: A Single-Arm Pilot Clinical Trial.结合肺炎球菌疫苗对代谢疾病患者血浆中抗氧化型低密度脂蛋白抗体水平的影响:一项单臂先导性临床试验。
Antioxidants (Basel). 2021 Jan 18;10(1):129. doi: 10.3390/antiox10010129.
脂质诱导的信号传导导致肝细胞释放炎性细胞外囊泡。
Gastroenterology. 2016 Apr;150(4):956-67. doi: 10.1053/j.gastro.2015.12.037. Epub 2016 Jan 5.
4
Current efforts and trends in the treatment of NASH.目前治疗 NASH 的方法和趋势。
J Hepatol. 2015 Apr;62(1 Suppl):S65-75. doi: 10.1016/j.jhep.2015.02.041.
5
NAFLD: a multisystem disease.非酒精性脂肪性肝病:一种多系统疾病。
J Hepatol. 2015 Apr;62(1 Suppl):S47-64. doi: 10.1016/j.jhep.2014.12.012.
6
Frequency and risk factors of low immunoglobulin levels in patients with inflammatory bowel disease.炎症性肠病患者免疫球蛋白水平低下的频率及相关危险因素。
Gastroenterol Rep (Oxf). 2015 May;3(2):115-21. doi: 10.1093/gastro/gou082. Epub 2015 Jan 30.
7
Circulating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies.循环微颗粒携带氧化特异性表位,并被天然IgM抗体识别。
J Lipid Res. 2015 Feb;56(2):440-8. doi: 10.1194/jlr.P054569. Epub 2014 Dec 18.
8
Serum immunoglobulin A concentration is a reliable biomarker for liver fibrosis in non-alcoholic fatty liver disease.血清免疫球蛋白A浓度是非酒精性脂肪性肝病中肝纤维化的可靠生物标志物。
World J Gastroenterol. 2014 Sep 21;20(35):12566-73. doi: 10.3748/wjg.v20.i35.12566.
9
Pancreatitis-associated protein has no additional value as a marker of disease activity in a real-life cohort of IBD patients.在现实生活中的炎症性肠病(IBD)患者队列中,胰腺炎相关蛋白作为疾病活动标志物并无额外价值。
Eur J Gastroenterol Hepatol. 2014 Aug;26(8):902-9. doi: 10.1097/MEG.0000000000000141.
10
Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease.血清免疫球蛋白水平可预测非酒精性脂肪性肝病患者的纤维化程度。
J Hepatol. 2014 May;60(5):1055-62. doi: 10.1016/j.jhep.2014.01.010. Epub 2014 Jan 18.